Patent intelligence · US
US 9095624
Modular transport platform for targeted delivery of therapeutic agents
Modular transport platform for targeted delivery of therapeutic agents
Patent details — US 9095624
- Jurisdiction
- US
- Status
- granted
- Grant date
- Aug 4, 2015
- Expiration
- Jul 30, 2035
- Applicant
- Contango Partners Group, Inc.
- Claims
- 15
- CPC classes
- A61K, A61K41/0071, A61K47/6415, A61K47/642
Quick answer
US 9095624 (Modular transport platform for targeted delivery of therapeutic agents) is held by Contango Partners Group, Inc.. Status: granted. Granted Aug 4, 2015. Expires Jul 30, 2035 (9 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Contango Partners Group, Inc.
- Grant date
- Expiration
- Claims
- 15
- CPC classes
- A61K, A61K41/0071, A61K47/6415, A61K47/642, A61K47/6445, A61K51/081
More from Contango Partners Group, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12403137
Compounds and methods of use
granted -
US 12304907
Compounds and methods of use
granted -
US 12264154
Compounds and methods of use
granted -
US 12043607
HDAC inhibitors and therapeutic use thereof
granted -
US 11999727
Compounds and methods of use
granted -
US 11986471
Compounds and methods of use
granted -
US 11492350
Compounds and methods of use
granted -
US 11077101
Compounds and methods of use
granted
Frequently asked questions
What is US patent 9095624?
US 9095624 (Modular transport platform for targeted delivery of therapeutic agents) is held by Contango Partners Group, Inc.. Status: granted. Granted Aug 4, 2015. Expires Jul 30, 2035 (9 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 9095624?
Contango Partners Group, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 9 pharmaceutical patents for this assignee.
When does US 9095624 expire?
Our index shows an expiration date of Jul 30, 2035 (9 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.